Counterfeit bulk drugs: hearings before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Sixth Congress, second session, June 8 and October 3, 2000, Volume 4
U.S. G.P.O., 2000 - Drugs - 423 pages
What people are saying - Write a review
We haven't found any reviews in the usual places.
Other editions - View all
aaqa adverse events Agency Agency's approved authentic Baker Bliley Bryant Burr CDER certificates of analysis Chairman China Commissioner Committee compliance concern counterfeit bulk drugs counterfeit drugs counterfeit pharmaceutical Criminal Investigations Cytotec database detect developed Dingell documents domestic dosage form Drug Administration drug imports drug listing drug products enforcement entry Evaluation FDA's FEII FEIt finished dosage finished drug Food and Drug foreign inspections Forensic Chemistry Fred Upton gentamicin sulfate Henney human drug identified import alert import inspectors imported counterfeit India industry issue labeling letter Long March manufacturing practices medicines mifepristone misoprostol OASIS pharmaceutical products pharmacies potential prescription drugs problem record regulatory reimportation reports requirements safety samples shipments shipped Strickland Stupak substandard surveillance testing U.S. Customs Service uaaq unapproved United